Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00794183 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval
A Early Phase 1 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT00794183: Clinical Trial Early Phase 1 study, sponsored by University of Minnesota.
NCT00794183 is a Early Phase 1 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 25 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00794183, a Early Phase 1 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The idea of this study is to compare different ways of setting up a pacemaker, using blood tests to give us information about how well it's working. We hope to learn if we can use this approach to figure out the best pacemaker setup ("programming") for each individual patient. The setting we propose to adjust is the timing between the impulse sent between top and bottom chambers.
Interventions
- DEVICE CRT device settings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2004-06 |
| Est. Completion | 2010-11 |
| Phase | Early Phase 1 |
Why NCT00794183 stopped before completion
NCT00794183 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which CRT device settings is the first listed.
NCT00794183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00794183 about?
NCT00794183 is a clinical study titled "A Pilot Study Comparing the Programmed Delay Between the Atrial and Ventricle Interval". The idea of this study is to compare different ways of setting up a pacemaker, using blood tests to give us information about how well it's working. We hope to learn if we can use this approach to figure out the best pacemaker setup ("programming") for each individual patient. The setting we propos...
What is the current status of trial NCT00794183?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2004-06. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00794183?
The interventions under investigation include: CRT device settings (DEVICE).
Who is sponsoring clinical trial NCT00794183?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00794183's enrollment target sits among peer trials
25 1000th of 2000 higher than 964 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia